NEW YORK, March 2, 2020 /PRNewswire/ -- EmblemHealth, one of the nation's largest non-profit health insurers, announced it was named the winner of two Stevie® Awards in the 14th annual Awards for Sales & Customer Service. EmblemHealth received a silver award for Innovation in Customer Service in recognition of its innovative work in serving the

PHILADELPHIA, March 2, 2020 /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) has received a $10 million gi

MONMOUTH JUNCTION, N.J., March 2, 2020 /PRNewswire/ -- 

CARY, N.C. and BASEL, Switzerland, March 2, 2020 /PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug de

Antony to Lead Neptune's Brand Retail Strategy, Leveraging More Than 30 Year Track Record at Unilever of Award-Winning Sales and Business Development LAVAL, QC, March 2, 2020 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), is pleased to announce today the appointment of

SAN JOSE, Calif., March 2, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, t

NEW YORK, March 2, 2020 /PRNewswire/ -- The American Optometric Association (AOA), the leading authority on quality care and an advocate for our nation's health, representing more than 30,000 doctors of optometry, announced today that it is working with Lyft, the transportation network, to offer free rides to people in select cities in an effort to make it easier to get

HAIKOU CITY, China, March 2, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that its subsidiary, Hainan Helpson P

NEW YORK and INDIANAPOLIS, March 2, 2020 /PRNewswire/ -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a Biologics License Application (BLA) for tanezumab 2.5 mg administered subcutaneously (SC), which is being evaluated for patients wi

STAINES-UPON-THAMES, United Kingdom, March 2, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced it i